» Articles » PMID: 34319679

The Impact of Hydrocephalus Shunt Devices on Quality of Life

Overview
Date 2021 Jul 28
PMID 34319679
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite advances in hydrocephalus shunt technology and improvement in hydrocephalus management, many patients have chronic disability and require multiple surgeries throughout their lifetime. There is limited data from patients' perspective regarding the impact of shunt devices on quality-of-life.

Methods: A cross-sectional survey was developed to evaluate the impact of shunt devices on patient quality-of-life. The survey was distributed via social media platforms of the Hydrocephalus Association, and patients self-selected to anonymously complete the online questionnaire. A literature review was performed to contextualize the findings from the survey.

Results: A total of 562 survey responses were obtained from a network encompassing 35,000 members. The mean age was 30 years old (0.5-87), and 65% identified as female. Eighty one percent underwent at least 1 shunt revision surgery, with a reported average of 10 shunt revision surgeries per patient (1-200 surgeries). Occlusion, shunt migration and infection were the leading causes for revision at 60%, 47%, and 35%, respectively. In addition, 72% of patients reported pain and discomfort from the device, and 68% expressed avoidance of certain activities due to "fear of bumping shunt." Despite numerous articles discussing shunt technology, a review of the literature indicated a paucity of studies specifically evaluating the burden of shunt devices from a patient/caregiver perspective.

Conclusions: The findings from this study suggest long-term physical and psychosocial burden associated with shunt devices. Importantly, this study highlights the need for concerted efforts to develop validated tools to study patient reported outcomes as it relates to neurocranial implanted devices.

Citing Articles

Research priorities for non-invasive therapies to improve hydrocephalus outcomes.

Hochstetler A, Hehnly C, Dawes W, Harris D, Sadegh C, Mangano F Fluids Barriers CNS. 2025; 22(1):24.

PMID: 40033423 PMC: 11877769. DOI: 10.1186/s12987-025-00632-1.


The long-term outcome of children with VP shunt and hydrocephalus: motor developmental outcome and QOL of patients with hydrocephalus is associated with the number of revisional procedures but is not impacted by the type of the valve.

Wendling-Keim D, Luz H, Kren E, Muensterer O, Lehner M Front Surg. 2025; 12:1530041.

PMID: 39931091 PMC: 11808032. DOI: 10.3389/fsurg.2025.1530041.


Discrepancies in Subjective Perceptions of Hydrocephalus Management and Self-Reported Outcomes.

Zipfel J, Filip Z, Kohlmann-DellAcqua C, Noell S, Trakolis L J Clin Med. 2024; 13(23).

PMID: 39685663 PMC: 11642199. DOI: 10.3390/jcm13237205.


Complement Inhibition Reduces Early Erythrolysis, Attenuates Brain Injury, Hydrocephalus, and Iron Accumulation after Intraventricular Hemorrhage in Aged Rats.

Zhang T, Xia F, Wan Y, Xi G, Ya H, Keep R Transl Stroke Res. 2024; .

PMID: 38943026 DOI: 10.1007/s12975-024-01273-6.


Can diffuse reflectance spectroscopy identify shuntodynia in pediatric hydrocephalus patients?.

Kline O, Vishwanath K, Colbrunn B, Peachman A, Zhang J, Vadivelu S J Biomed Opt. 2024; 29(3):037002.

PMID: 38476219 PMC: 10929735. DOI: 10.1117/1.JBO.29.3.037002.